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Abstract: Here, we present a new class of third harmonic generation (THG) imaging probes 
that can be activated with precise spatiotemporal control using non-linear excitation. These 
probes consist of lipid-coated perfluorocarbon nanodroplets with embedded visible 
chromophores. The droplets undergo phase transition from liquid to gas upon heating 
mediated by two-photon absorption of NIR light by the embedded dyes. Resulting 
microbubbles provide a sharp, local refractive index mismatch, which makes an excellent 
source of THG signal. Potential applications of these probes include activatable THG agents 
for biological imaging and “on-demand” delivery of various compounds under THG 
monitoring. 
© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction 
Advances in imaging technologies and respective contrast agents have greatly expanded our 
understanding of tissue structure, cell functions and interactions as well as subcellular events 
from basic cell biology to oncology [1–5]. Advanced microscopy exploits a range of contrast 
strategies to detect structural, molecular, and physical cell and tissue properties, and there is 
growing need for pairing of imaging modalities with innovative contrast agents. 
Most contrast agents in life sciences today rely on the principle of single- or two-photon 
excitation. While these agents are extremely useful in generating imaging contrast, there are 
constraints in the number of unique targets that can be imaged due to spectral overlap in the 
visible light range. Additionally, scattering and absorption of both the visible excitation 
sources and emissions by the contrast agents present a challenge to 3D in vitro and in vivo 
imaging [6]. The development of multiphoton microscopy with pulsed near-red and infrared 
laser excitation sources enabled in vivo imaging of live cells and tissue structures at high 
resolution, low phototoxicity, and reasonable depth of penetration (300-1000 µm) [7–11]. 
Furthermore, the possibility of higher harmonic imaging by second harmonic generation 
(SHG) and third harmonic generation (THG) enables additional modes of endogenous tissue 
contrast and opportunities for development of exogenous contrast agents which report by 
fluorescence-independent mechanisms. SHG occurs when biological structures containing 
asymmetric repetitive units (e.g. striated muscle and collagen fibers) convert two photons of 
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an excitation light source into a single emitted photon at double the energy (1/2 of the 
excitation wavelength). THG occurs at interphases, typically with a refractive index mismatch 
(e.g. water-lipid/protein), that results in conversion of three photons of an excitation light into 
a single emitted photon with triple the energy (1/3 of the excitation wavelength) [12]. 
Whereas SHG is limited to asymmetry of the structure being imaged, THG is based on 
differences in refractive index and, hence, is more broadly applicable. Unlike fluorescence, 
THG does not suffer from photobleaching or generation of reactive oxygen species [12] and 
allows detection of intrinsic complex tissue structures with subcellular resolution, including 
interstitial tissue, cell surfaces, and microvesicles in live animals [13]. 
Such advantages prompted development of specific THG imaging contrast agents for 
specialized applications in life sciences requiring unique labeling or increased contrast. For 
biologically relevant THG imaging, these agents include lipid-enclosed quantum dots [14], 
lipid microbubbles [15], tattoo dye [16], porphyrin aggregates [17], bismuth ferrite [18] or 
titanium dioxide [19] nanoparticles. These constitutive THG probes can enable cell tracking 
applications [14,18], as well as molecular imaging through conjugation with targeting 
moieties, e.g., antibodies or peptides [15]. However, they also suffer from the complexity of 
THG signals originating in 3D tissue and the generic nature of the signal which might not be 
readily discriminated from the background. To increase specificity, activatable or externally 
triggered THG probes could offer new sensing capabilities in biomolecular imaging by 
creating on demand contrast or enabling image-guided interventions and delivery, not unlike 
activatable fluorescence probes [20–24]. Here we address this need by developing and 
initially validating spatiotemporal, inducible contrast probes for THG imaging that are based 
on phase changing perfluorocarbon (PFC) nanodroplets. We applied highly localized two-
photon excitation to trigger phase-change of PFC nanodroplets and THG visualization of the 
resulting microbubbles post-excitation dynamics. The spatiotemporal precision of 
nanodroplet activation could allow utilization of these agents for spatially and temporally 
controlled on-demand image-guided delivery, which is not possible with previously reported 
agents. 
The nanodroplets consist of a lipid-stabilized PFC core with embedded light absorbing 
dye molecules. Previously, these nanoparticles were used to create a high signal and contrast 
in photoacoustic imaging [25–27]. In these studies, excitation of the nanodroplets occurs with 
nanosecond laser pulses, which are matched with the absorption band of an embedded dye, 
followed by a liquid to gas transition of the PFC core which elicits a strong photoacoustic 
signal. Using this principle, we recently demonstrated that the phase changing PFC 
nanodroplets can also be used to create localized, high frequency elastic waves in optical 
coherence elastography measurements [28,29]. PFC with relatively low boiling temperatures, 
e.g. perfluoropentane or perfluorohexane, are generally used to facilitate the liquid-gas phase 
transition. These compounds are highly inert and non-toxic materials and have been 
successfully used in variety of biomedical applications including blood substitutes [30–35] 
and in vivo imaging [36,37]. 
We hypothesized that after conversion of a nanodroplet into a microbubble, the distinct 
interphase between aqueous surrounding and the PFC gas will provide a sharp, local 
refractive mismatch and therefore elicit THG. To demonstrate applicability of these 
nanodroplets in 3D settings, we applied infrared two-photon excitation of the embedded dye 
molecules to promote liquid to gas phase transition of PFC nanodroplets and recorded precise, 
spatiotemporally controlled nanodroplet activation. The results reveal a first-in-field phase-
change nanodroplet system for spatially and temporally controlled and activatable probes for 
THG imaging. 
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2. Materials and methods 
2.1 Synthesis and assessment of nanodroplets 
The nanodroplets were synthetized from a liquid dodecafluoropentane core coated by a 
mixture of phospholipids and Cyanine 3 (Cy3) dye molecules. The formulation was adopted 
from a previously described protocol [28]. Briefly, 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-
polyethyleneglycol-2000 (DSPE-PEG-2000), and cholesterol (all from Avanti Polar Lipids, 
Inc.) were dissolved in 2 mL of chloroform at a weight ratio of 90:8.5:1.5, respectively, and 
the total mass of 20 mg. The mixture was dried in a rotary evaporator (Cole-Palmer 
Instrument Company, LLC.) at 40°C for 30 minutes to form a lipid cake. Then, 2 mL of 
deionized water was added to the lipid cake and the vial was shaken at 250 rpm on ice for 30 
minutes. Simultaneously with the lipid hydration process, 125 µL of dodecafluoropentane 
(FluoroMed L.P.) was mixed with 100 µL of 1% (v/v) aqueous solution of 1H,1H,2H-
Perfluoro-1-hexene,3,3,4,4,5,5,6,6,6-nonafluoro-1-hexene (Zonyl PFBE, Sigma-Aldrich 
Corp.) and 150 µL of 2 mg/mL aqueous solution of Cy3 dye (Lumiprobe Corp.). This core 
mix was vortexed for 20 seconds and then sonicated in a benchtop ultrasonic bath CPX-962-
218R (Fisher Scientific) in ice-cold water for 30 seconds. Subsequently, 2 mL of rehydrated 
phospholipids were added to the core mixture of PFC, Cy3 dye, and Zonyl PFBE. The 
suspension was vortexed for 30 seconds and then sonicated in the benchtop ultrasonic bath in 
ice-cold water for 1 minute. Final sonication was carried out using the VCX 500 ultrasound 
probe with a 2 mm tip (Cole Palmer) for two 1 minute cycles at 25% maximum amplitude; 
the cycles were separated by 20 seconds of vortexing. Then, the suspension was kept on ice 
for 5 minutes and was washed twice with water at 3100 G for 15 minutes to remove the 
excess of free dye and lipids. The final pellet of washed nanodroplets was re-suspended in 1 
mL of deionized water. Blank nanodroplets (containing no dye) were synthesized using the 
same protocol except deionized water was added to the core mix instead of the dye solution. 
Average size of the nanodroplets was measured by dynamic light scattering using 
intensity (Delsa Nano C, Beckman Coulter, Inc.). To confirm dye inclusion inside the 
nanodroplets, fluorescence intensity of blank and dye-containing preparations were measured 
with Synergy HT microplate reader (BioTek Instruments, Inc.) using 530/25 and 590/35 nm 
excitation/emission filters. 
PFC concentration in nanodroplet preparations was measured using 19F NMR. Briefly, 10 
µL of a nanodroplet suspension were mixed with 400 µL of deionized water, and 75 µL of 
0.5% reference solution of trifluoroacetic acid in deuterium oxide (both from Sigma-Aldrich 
Corp.) in a 5 mm NMR sample tube (Wilmad-LabGlass). One-dimensional 19F NMR was 
performed with a 500 MHz NMR spectrometer (Bruker Corporation). Typical acquisition 
parameters included acquisition time of 0.577 s, signal averages - 16 (with phase cycling) and 
a relaxation delay of 15 s. Spectral amplitudes were corrected for incomplete relaxation and 
fluorine quantification was carried out by integrating peaks and comparing the sample’s peak 
to the reference peak from trifluoroacetic acid standard. 
2.2 Phantom preparation 
Polyacrylamide (10%, PAA) phantoms were made by adopting a previously described 
protocol [38]. Briefly, 125 µL of 40% acrylamide aqueous solution (Ambion Inc.), 7.5 µL of 
438 mM aqueous solution of ammonium persulfate (Sigma-Aldrich Corp.), 0.75 mg of 
nanodroplets (in terms of PFC concentration, the corresponding volume was varied depending 
on a preparation but was typically 20-60 µL), 2 µL of tetramethyl ethylenediamine (Sigma-
Aldrich Corp.), and deionized water to bring the final volume up to 500 µL were mixed 
together and poured inside of a 20 mm diameter and 2 mm high silicone isolator (Grace Bio-
Labs) attached to a macroscopy slide. Isolators were sealed with a 24 x 24 mm cover glass 
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(Fisher Scientific) and the mixture was allowed to polymerize to a 10% PAA gel at room 
temperature for 20 minutes before imaging. 
2.3 Multiphoton microscopy imaging 
Imaging was performed on a custom multiphoton microscope (TriMScope-II, LaVision 
BioTec), equipped with three tunable Ti:Sa (Coherent Ultra II Titanium:Sapphire) lasers and 
two Optical Parametric Oscillators (OPOs; Coherent APE). Power under the objective was 
controlled by attenuators in the beams paths and measured before each experiment. A long-
working distance, 25x NA 1.05 water immersion objective (Olympus) was used for image 
acquisition. Multi-spectral detection was performed using up to 3 GaSP photomultipliers 
(PMTs, Hamamatsu) in the backward configuration using sequential single or dual excitation 
wavelengths scans for z-stack, zoom and overview, and time lapse acquisitions. The 
following excitation and emission channels were collected where indicated: Lifeact-GFP and 
calcein AM (920 nm; 525/50 nm); H2B-mcherry (1090 nm or 1100 nm; 620/60 nm), SHG 
(1090 nm; 525/50 nm), and THG (1280 nm; 420/50 nm). Nanodroplets were excited with 
1090 nm or 1100 nm two-photon excitation (100-200 mW measured under the objective) and 
phase-change induced THG signals were detected using 1280 nm multi-photon excitation 
using 80-110 mW under objective in cell culture in vitro which is comparable for imaging in 
the mouse dermis in vivo. Time-lapse recordings were performed by acquiring images every 2 
seconds for 200 to 400 seconds. The 1090 nm or 1100 nm wavelength for nanodroplet 
activation was applied for continuous intervals to generate THG signals. Single time point, 
3D multichannel z-stacks were acquired with z step sizes of 3 µm. Scan fields had a pixel 
dwell time of 4 µs (imaging in ND suspensions) and 8.9 µs (imaging in gel phantoms and 
collagen matrix). 
2.4 THG signal and image analysis 
THG signal and image analysis was performed using Fiji/ImageJ2 [39], Excel (MS) and 
results were displayed with GraphPad Prism 7. To measure the dependence of signal 
generated by activated PFC nanodroplets on excitation power, Cy3 PFC nanodroplets were 
first excited using 1100 nm (~110 mW) in imaging media, phosphate buffered saline with 
Ca2+ and Mg2+ (Sigma-Aldrich Corp) and 10% fetal bovine serum (Cellgro) mixed with 20 
µL of nanodroplets, and 1280 nm excitation (~90 mW) to obtain microbubble signal emission 
(420/50 nm). Once microbubbles were detected, photoactivation at 1090 nm was ceased and 
1280 nm excitation over a range of available powers (89-186 m W) was used alone to collect 
single images from the induced microbubbles at a single focal plane. The mean intensity of 5 
microbubbles from 4 independently excited positions in cell culture was quantified using 
MaxEntropy thresholding (Fiji). Signal-power data set were log-log transformed and 
individually fitted using a linear regression. The R2 values for all 5 fits was > 0.97. The mean 
of the slopes (slopem) determined from each data set was calculated and reported with the 
standard deviation (slopem = 2.92 ± 0.53). For display, all log-log transformed data sets were 
plotted together with a fit line (mean slope and y-intercept of the individually modeled data 
sets). 
Quantification of THG signals induced at defined z positions (Fig. 4(a)) in PAA gels was 
performed by first measuring the raw integrated density (total intensity) of each z slice of the 
acquired 3D stack. Background signal was estimated by using the Yen threshold method in 
Fiji and measuring the raw integrated density (bkg-intensity) for the identified background 
area for each z slice. Final THG intensity (AU) was reported as the difference between the 
total intensity and the bkg-intensity as determined above and then plotted as a function of the 
z position (μm). 
Size distribution of THG microbubbles formed in solution was estimated from time-lapse 
imaging data. Background intensity of time-lapse recordings was estimated by measuring the 
mean intensity of the first 25 images (where no nanodroplets were excited). All time-lapse 
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images were background corrected with this value. THG signal was discriminated from 
background using the Moments threshold method in combination with particle analysis to 
identify THG positive events of at least 2 square pixels in dimension (~0.6 µm2). The areas of 
all identified THG pixels were measured. Assuming that all THG microbubbles are spherical 
upon formation and appear circular during single focal plane detection, the measured areas 
were converted into an ‘apparent’ circular diameter for size distribution analysis. 
2.5 Cell culture, collagen matrix embedding and viability test 
Mouse mammary 4T1 carcinoma cells stably expressing nuclear (H2B-mCherry) and actin 
filament binding (Lifeact-GFP) fluorescent reporters were maintained at 37°C and 5% CO2 in 
RPMI-1640 medium (Sigma-Aldrich Corp.) supplemented with 10% fetal bovine serum 
(Cellgro Corning), 100 U/mL penicillin and 100 µg/ml streptomycin (Hyclone ThermoFisher) 
and 1% sodium pyruvate (ThermoFisher). Cells were detached with EDTA (1mM) and 
trypsin (0.5%) and the collected cell suspensions were incorporated into type I collagen from 
rat-tail tendon (BD Biosciences; final concentration 2.5 mg/mL) followed by gel 
polymerization at room temperature as described previously [40,41]. Using either the same 
silicon isolator and setup as for the PAA phantoms or a 35 mm glass bottom µ-Dish (ibidi 
GmbH), polymerized cell-containing collagen matrix was overlaid with culture or imaging 
media (1-3 mL) mixed with 40-120 µL of PFC nanodroplets in water and imaged after 20-30 
minutes. 
Human HT1080 fibrosarcoma cells stably expressing nuclear (H2B-mCherry) and actin 
(Lifeact-GFP) fluorescent reports were maintained in DMEM medium (Gibco/ThermoFisher) 
and supplemented with 10% fetal bovine serum (Cellgro Corning), 100 U/mL penicillin and 
100 µg/ml streptomycin. After detachment and embedding into 3D collagen gels, as described 
above, cells were treated with 4-10 μM calcein AM (Corning) for 15 min, washed, treated 
with 1 mL imaging media (method 2.4) mixed with 20-40 µL of ND-Cy3 nanodroplets as 
above, and cell viability was tested after nanodroplet activation. 
3. Results and discussion 
3.1 Nanodroplets characterization 
The nanodroplets consisted of a liquid PFC core coated with a mixture of PEGylated 
phospholipids, and embedded Cy3 dye molecules (Fig. 1(a)). The phospholipid coating 
stabilizes PFC nanodroplets in an aqueous environment while PEG provides protection from 
nonspecific interactions and Cy3 chromophores with an absorbance maximum at 550 nm 
were embedded to enable two-photon absorption and photoactivation. Nanodroplet-
containing aqueous solution displayed characteristic purple coloring when Cy3 dye was 
embedded (Fig. 1(b)). Typical preparations resulted in fairly uniform size distributions of 
nanodroplets with average sizes at the major distribution peak of 379 ± 96 nm and 306 ± 80 
nm for PFC nanodroplets with embedded Cy3 chromophores (ND-Cy3) and “blank” PFC 
nanodroplets without dye molecules (ND-B) specimen, respectively (Fig. 1(c)). Fluorescence 
intensity measurements confirmed dye inclusion inside the ND-Cy3 nanodroplets (Fig. 1(d)). 
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 Fig. 1. (a) Schematic of a nanodroplet with lipid coating and PFC core containing dye 
molecules (ND-Cy3); (b) a photograph of washed preparations of “blank” nanodroplets with 
no dye (ND-B, left) and ND-Cy3 (right); (c) size distributions of nanodroplets measured by 
dynamic light scattering (intensity distribution); (d) difference in fluorescence between washed 
ND-B and ND-Cy3 nanodroplets at the same concentrations. 
3.2 Two-photon activation of PFC phase-change nanodroplets 
The nanodroplets were designed to enable an externally triggered phase-change by 
incorporating a visible dye to absorb incoming NIR photons through a two-photon absorption 
process. The choice of the perfluoropentane as the core material was driven by its relatively 
low boiling temperature of 29°C in bulk. It is important to note, that the boiling temperature is 
inversely proportional to nanodroplet size due to increase in the surface tension [42–44]. We 
hypothesized that two-photon excitation would induce a liquid-gas phase change of the PFC 
core through the highly localized heating created by the embedded chromophores resulting in 
an interface between aqueous surroundings and the PFC microbubble that can be detected by 
THG microscopy. 
To confirm this hypothesis, we activated ND-Cy3 with 1100 nm two-photon laser 
excitation (or 1090 nm) tailored to the predicted two-photon absorption peak of Cy3. 
Previously, it was shown that two-photon fluorescence of Cy3 labeled IgG immunoglobulins 
can be excited in the range of ~930-1150 nm with the maximum two-photon fluorescence at 
1032 nm [45]; this data indicate that the optimum two-photon absorption peak of Cy3 might 
differ from the predicted value. However, our two-photon imaging system did not have 
sufficient power at wavelengths below 1080 nm for nanodroplet activation, therefore, we used 
the 1100 nm excitation. Any THG signals resulting from the phase transition were excited 
using a higher infrared wavelength (1280 nm), which does not excite Cy3 dye, and detected at 
395-445 nm, which is below the Cy3 emission. 
Each nanodroplet preparation with or without the dye was embed in 10% PAA phantoms. 
All samples were continuously imaged (image acquired every 2 seconds) with a 1280 nm 
laser for the duration of the experiments (200 to 400 seconds) in order to detect any phase-
change signals (Fig. 2(a) schematic). We first confirmed that continuous 1280 nm excitation 
alone over a period of 50 seconds did not elicit any signals in ND-Cy3 samples (Fig. 2(b)). 
Addition of the Cy3 excitation laser (1100 nm) resulted in formation of phase-change signals 
in the THG emission channel (Fig. 2(c)). After discontinuation of 1100 nm excitation, the 
phase-transition signal originating from microbubbles persisted for at least 50 sec (Fig. 2(d)). 
In contrast, little to no signal was induced when 1100 nm excitation was applied to dye-free 
ND-B blank nanodroplets for extended time periods (350 sec) (Figs. 2(e)–2(g)). A small 
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number of sporadic phase-transition signals observed in some ND-B samples after a long 
observation period are most likely due to spontaneous phase change in some of the bigger and 
thus less stable PFC nanodroplets (Fig. 2(g), arrowhead). 
 
Fig. 2. Phase-change of nanodroplets with applied two-photon excitation. (a) Schematic of the 
experiment. Note, that both laser beams were delivered through the same objective. Single 
focal planes in gels with embedded ND-Cy3 (b, c, d) and ND-B (e, f, g) were continuously 
imaged with 1280 nm excitation for phase-change signal detection. No signal was registered in 
ND-Cy3 sample before 1100 nm excitation that was started after 50 seconds (b). Phase-change 
signal was registered during (c) 1100 nm laser excitation and (d) after its removal at 350 
seconds. A similar sequence with extended 1100 nm excitation showed minimal signals for 
ND-B (e) before, and (f, g) during 1100 nm laser excitation starting after 50 and ending at 400 
seconds; an arrowhead points to a rare, sporadic event. Scale bars = 10 µm. 
In general, the liquid-gas phase transition is expected to result in up to ~5-6 fold volume 
increase based on the difference in density between gaseous and liquid phases of PFC [42,46]. 
However, previous studies of ultrasound activated PFC phase transition from nano- or micro-
droplets to microbubbles showed a volume increases in excess of 10-fold [42,46–49]. The 
extra bubble expansion was shown to be associated with diffusion of dissolved gases from the 
surrounding media into the activated microbubbles due to an order of magnitude higher 
solubility of some gases in perfluorocarbon in comparison to water [50]. Consistently, PFC 
nanodroplets, with an average initial size just under 400 nm, reached sizes of ~4 µm in 
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 Fig. 5. THG detection of PFC phase-change during 2-photon excitation of a ND-Cy3 
suspension. (a) A small region (44x44 µm) in a water solution of ND-Cy3 nanodroplets was 
subjected to continuous (0-200 seconds) excitation with 1280 nm for detecting THG signals 
and after 50 seconds dually excited with activating 1090 nm laser (~168mW). THG signals 
were observed forming over time under dual excitation (b, c) and then the THG signal 
disappeared once 1090 nm excitation was removed at 150 seconds (d). Imaging concluded at 
200 s. Scale bar = 5 µm (e) Size distribution of the THG signals over duration of the 
experiment. 
3.6 Activation of nanodroplets in 3D cell culture 
For preliminary validation of the potential utility of dye-loaded PFC nanodroplets in 
biological studies, we generated 3D collagen matrix with embeded 4T1 mouse breast cancer 
cells expressing nuclear H2B-mCherry and Lifeact-GFP detecting actin filaments [55]. 
Culture media mixed with ND-Cy3 was incubated with the 3D cell culture before 
multiphoton imaging. Similar to our method of imaging phantom and suspension samples, 3D 
cell cultures were initially imaged using 1280 nm laser excitation (0-52 seconds) to confirm 
the absence of non-specific induction of THG (Fig. 6(a)) followed by additional exposure to 
1090 nm excitation for nanodroplet activation (during 52-100 seconds in the imaging 
sequence). We observed time dependent activation of the nanodroplets, with the emerging 
THG signals adjacent to the cells between 52 to 100 seconds of 1090 nm excitation (Fig. 6(b) 
and Visualization 3). Most of the microbubbles appear to form extracellularly (see arrows in 
Figs. 6(b) and 6(c)), although, we cannot exclude the possibility of some nanodroplets been 
also endocytosed by cells. As in the case of PAA phantoms, the initially formed microbubbles 
underwent a significant size expanson over time after 100 seconds despite removal of the 
1090 nm laser (Figs. 6(c)–6(f) and Visualization 3). There were apparent coalescence events 
contributing to growth of the microbubbles (Figs. 6(d)–6(f) and Visualization 3). Differences 
in the expansion of microbubbles are most likely asociated with local non-uniformity of 
nanodropet distribution in the cell culture as well as non-uniformities in activation of liquid-
gas phase transition of PFC nanodroplets due to differences in their dye loading and sizes. 
The microbubbles with bigger initial sizes can undergo faster growth due to the Oswald 
ripening effect and coalescence of bubbles and/or bubbles with droplets as described in 
Section 3.2. THG signals were confined to the activated area demonstrating controlled spatial 
activation (Fig. 6(g)). Fate-tracing of activated nanodroplets indicates interactions with cell 
surfaces and potentially integration of the plasma membrane of the adjacent cells into coating 
of the growing microbubbles (Figs. 6(d)–6(f) and Visualization 3). 
Notably, the mCherry signal inside the activated area was diminished after exposure to 
photoactivation, suggestive of photobleaching (Fig. 6(g), dashed box). To test this assumption 
we carried out an experiment where mCherry expressing cells were labeled with calcein AM 
vital dye and were exposed to 1090 nm laser at 102 mW for 150 seconds to mimick 
conditions of nanodroplet activation used in our studies (data not shown). A continuous decay 
in the mCherry signal was observed with no decay in the calcein AM fluorescence indicating 
photobleaching of mCherry label whithout photo-cytotoxicity. 
                                                                      Vol. 10, No. 7 | 1 Jul 2019 | BIOMEDICAL OPTICS EXPRESS 3310 
Fig. 6
52-10
snapsh
disper
secon
(0-400
nanod
observ
activa
examp
coales
power
area (
signal
To furthe
embedded hu
H2B-mCherry
with calcein A
measure for 
background o
to the sample
cytoplasm, in
the nanodropl
THG using e
monitored wi
were formed 
appeared to in
loss of calcein
microbubble p
that was in c
remained unp
calcein AM si
Our data d
cells through 
studies are n
spatiotempora
show promise
. ND-Cy3 nanodr
0 seconds 1090 n
ot 1090 nm and
sed in collagen I 
ds). THG and GF
 seconds) while 
roplets (see Meth
ed forming near
tion, THG microb
les of small (d, 
cence into larger 
; nuclei only), an
dashed box) show
 was photobleache
r investigate 
man HT1080 
 (nuclei) and 
M, a vital d
cell viability. 
f LifeAct-GFP
. Pre-nanodro
dicative of an 
ets was activa
xcitation at 1
th 920 nm and
in vicinity of 
tegrate with t
 AM signal (F
roximal to ce
lose vicinity t
erturbed (Figs
gnal in cell 2 d
emonstrate tha
pushing, cell 
eeded to fu
ly controlled 
 that such appl
oplets excited in 3
m and 1280 nm;
 1280 nm. (a) Si
matrix at the start
P-Lifeact/actin sig
collagen and cell 
ods). (b) During 
 cells (examples 
ubbles evolve (c-
e – solid arrow
microbubbles. (g) 
d 1280 nm (THG
s spatially induce
d, however cell m
the impact o
fibrosarcoma 
LifeAct-GFP 
ye that allows
Cytoplasmic 
 (Fig. 7(e)). D
plet activation
intact plasma 
ted with 1100 
280 nm. Subs
 1280 nm, res
cells 1 and 3
he cell plasm
ig. 7(d)), indi
ll 3 led to loss
o the formed 
. 7(b)–7(d)). O
id not fade, in
t activated mi
displacement,
lly realize th
delivery and a
ications are w
D collagen matrix
 102-400 second
ngle focal plane 
 of start of two-p
nals are detected
nuclei are detecte
~50 seconds of 10
are marked by 
f) and expand int
s) and large (e, 
Overview using 9
) ~6 minutes post
d THG microbub
orphology remain
f activated m
cells (a mesen
(actin) into 3D
 to assess the
calcein AM s
ye-loaded PFC
, cells showe
membrane (F
nm for 78 sec
equently, the 
pectively. In a
. The growing
a membrane (
cative of the c
 of calcein AM
microbubbles 
f note, despi
dicating prolo
crobubbles can
 and disruptio
e potential o
ctivatable THG
ithin reach. 
 with cancer cells
s 1280 nm; 460 
of 4T1 murine b
hoton (1090 nm) 
 by continuous 12
d by 1090 nm du
90 nm excitation
arrowheads in b 
o cells. Continuou
f – dashed arrow
20 nm (actin), 10
 ND-Cy3 activati
bles; note that the
ed intact. Scale b
icrobubbles 
chymal cell t
 collagen ma
 integrity of t
ignal was cle
 nanodroplets
d strong calce
ig. 7(a)). Liqu
onds under co
calcein AM a
n example in 
 microbubble
Fig. 7(c)), and
ell death. Sim
 signal (Figs
without a dir
te imaging for
nged viability.
 cause mecha
n of cell mem
f our nanod
 agents, but t
. Laser sequence
seconds overview
reast cancer cells
excitation (t = 52
80 nm excitation
ring excitation of
, THG events are
and in c). Post-
s imaging shows
s) microbubbles
90 nm (at reduced
on of the defined
 nuclear mCherry
ars = 20 µm. 
on cell integ
ype) stably ex
trix. Cells wer
he cell membr
arly detectabl
 were topicall
in AM signa
id-gas phase c
ntinuous moni
nd THG sign
Fig. 7(b) micr
 in contact wi
 thus was foll
ilarly, expansi
. 7(c) and 7(d
ect mechanica
 up to 60 min
 
nical stress to 
branes. Clear
roplets as ag
hese early exp
 
: 
 
 
 
 
 
 
 
 
 
 
 
rity, we 
pressing 
e loaded 
ane as a 
e on the 
y applied 
l in their 
hange of 
toring of 
als were 
obubbles 
th cell 1 
owed by 
on of the 
)). Cell 2 
l contact 
utes, the 
proximal 
ly, more 
ents for 
eriments 
                                                                      Vol. 10, No. 7 | 1 Jul 2019 | BIOMEDICAL OPTICS EXPRESS 3311 
Fig. 7
(calce
secon
nm an
mChe
activa
proxim
and c
minut
pertur
calcei
nm). S
4. Conclusio
Here we desc
phase-change
the nanodropl
activation pro
possibilities o
demand’ usin
or biologicall
molecules us
nanodroplets 
identifying n
microscopy a
cellular functi
The range
as the typica
between 5 an
and power, th
the observatio
despite high n
1280 nm) in v
frame per se
photodamage 
without interv
experiments a
frames (~80 s
condition tha
Accordingly, 
to 60 minute
loading effici
required to in
perfluorocarb
the perfluoroc
. Impact of micro
in AM) and 1100 
ds 1100 nm (activ
d 1280 nm for a
rry and Lifeact-G
tion of ND-Cy3 
al to cells 1 and 
alcein AM signal
e for up to 60 min
bation of cells 1 a
n AM signal (i) 
cale bar = 25µm.
ns and pers
ribe a new cl
 PFC nanodro
et-embedded 
cess occurs in
f applying th
g two-photon e
y active agent
ed in this stu
toward label
iches of enz
nd novel THG
ons (malfuncti
 of 100-200 m
l time-lapse i
d 130 mW [13
e period of ob
n period, and
ominal excita
ivo is acceptab
cond) for ov
is observed at
als [13]. Curr
t powers of 1
econds total e
t can cause ad
this cumulativ
s, using vital 
ency into the
duce the liqu
on-soluble chr
arbon core th
bubble interaction
nm (mCherry); 0-
ation of PFC nan
ll other times. (a)
FP pre-labeled w
nanodroplets. (b
3 following activa
s were monitored
utes. Inset shows
nd 3 by expandin
dominates endoge
 
pective 
ass of activata
plets. The age
dye molecules
 a spatially an
ese nanoparti
xcitation unde
s, could be in
dy [44,56,57]
ing cells and
ymatic/metabo
 agents has th
ons) and diagn
W for two-pho
maging with 
,55,58–60]. P
servation, ins
 absorption/sc
tion power, ph
le at a high po
er 230 frame
 a slower rate 
ently, we are 
15-134 mW at
xposure). The
verse effects 
e exposure wa
staining with 
 PFC nanodro
id-gas phase t
omophores [61
at could perm
s with cells. Lase
50 seconds 1280 
odroplets) and 12
 HT1080 cells (n
ith vital dye calce
) Microbubble fo
tion of nanodropl
 using 1280 nm 
 all 3 cells in col
g microbubbles p
nous HT1080 Li
ble agents for
nts respond to
, expand, and
d temporally c
cles as nanoc
r THG monito
corporated ins
. We further 
 extracellular
lic activity. 
e potential to 
ostic medicin
ton excitation
two-photon ex
hotodamage is
tantaneous an
atter of the in
otodamage ca
wer of 130 m
s taken over 
of 0.6 frame p
able to excite
 a rate of 0.73
se excitation p
in biological 
s not cytotoxi
calcein AM. 
plets in orde
ransition. One
–64]; these m
it significantl
r sequence: t = 0
nm (THG and cal
80 nm (THG and 
umbered arrows)
in AM in a colla
rmation is visibl
ets with 1100 nm 
and 920 nm, resp
lagen matrix. (c a
ost activation. (e)
feact-GFP (ii) sig
 THG that ar
 two-photon l
 generate stro
ontrolled man
arriers for de
ring. Various
ide the nanod
envision appl
 matrix spec
Such pairing
provide new i
e. 
 of the nanopa
citation is ca
 a function of
d cumulative 
cident light by
used by infra
W with short s
3.8 hours [8
er second unde
 the nanodrop
 frames per s
arameters are 
samples when
c to cells with
We are work
r to significa
 promising d
odified dyes c
y decreased p
 snapshot 920 nm
cein AM); 52-132
calcein AM); 920
 expressing H2B-
gen matrix before
e as white spots
(~128 mW). THG
ectively, every 1
nd d) Mechanical
 Control showing
nal (~7 mW 920
e based on dy
aser light exc
ng THG contr
ner that offers
livery of a ca
 compounds, l
roplets akin to
ying variants 
ific proteins 
 of nonlinea
nsights into b
rticles is relati
rried out usin
 excitation wa
illumination re
 the tissue. T
red excitation 
can time per f
,13]. Howeve
r continuous 
lets in our ce
ec and exposu
just above the
 continuously
 follow-up im
ing on increa
ntly reduce th
irection is syn
an be solubiliz
ower for initi
 
 
 
 
 
 
 
 
 
 
 
e-loaded 
itation of 
ast. This 
 exciting 
rgo ‘on-
ike drugs 
 the dye 
of these 
and for 
r optical 
oth basic 
vely high 
g power 
velength 
lative to 
herefore, 
(1090 to 
rame (~1 
r, tissue 
scanning, 
ll culture 
re for 40 
 imaging 
 applied. 
aging up 
sing dye 
e power 
thetizing 
ed inside 
ating the 
                                                                      Vol. 10, No. 7 | 1 Jul 2019 | BIOMEDICAL OPTICS EXPRESS 3312 
liquid-phase transition. The THG excitation (80-100 mW) used for time-lapse detection of 
microbubble growth is comparable to THG imaging of cells in other studies in vitro and in 
vivo [12,13,65,66]. 
The effects of microbubble expansion on cell viability in direct vicinity may pose 
challenges in tissue imaging applications, but also open avenues for other applications. To 
control cell damage, we currently focus on minimizing the expansion of activated 
microbubbles starting with achieving a more uniform distribution of nanodroplets in cell 
cultures and optimizing nanodroplet concentration. For interventional purposes, we envision, 
for example, increasing permeation of blood vessels, e.g. in blood-brain barrier, via precise 
disruption of endothelium under THG monitoring. A similar concept was recently reported 
using microbubble-assisted focused ultrasound [67]. We thus foresee that the spatial precision 
of two-photon-mediated delivery as a tool in pre-clinical studies may offer particular 
opportunities for localized delivery. Likewise, locally triggered disruption of cancer cells may 
be exploited for release of cancer antigens for immunotherapy [68,69]. Finally, due to high 
level of interest in applications of PFC nanodroplets in photoacoustic and ultrasound imaging 
[38,70–72], it is important to have tools that would allow a high resolution longitudinal 
imaging of PFC nanodroplet activation in biological samples similar to our study presented 
here. 
Potential applications of the two-photon activatable phase-change nanodroplets could be 
greatly facilitated by the pioneering work of Professor Tuchin in the area of tissue optical 
clearing (TOC) [73–77]. This method is based on modifying refractive index of biological 
tissues that leads to reduction of tissue light scattering and making biological specimen more 
transparent [78]. The combination of multiphoton microscopy and TOC was shown to 
achieve depth of penetration in biological tissues exceeding 1000-2000 µm [79,80]. 
Therefore, application of TOC could significantly increase the depth in tissue where 
presented here activatable THG agents can be excited and imaged, thus extending the range 
of their potential applications. 
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